Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide first add-on treatment study in pediatric focal epilepsy
ChiCTR2600134986Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Nantong University
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of zonisamide in Focal Onset Epilepsy and focal to bilateral tonic-clonic seizure, sponsored by Affiliated Hospital of Nantong University. Primary endpoints: Change in seizure frequency and 50% responder rate. Started Aug 2024; status: recruiting.
02
Drugs
zonisamide
03
Conditions
Focal Onset Epilepsyfocal to bilateral tonic-clonic seizure
Beyond the preview
Go deeper on ChiCTR2600134986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600134986.